{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:30:58Z","timestamp":1789133458784,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Italy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007659","name":"Bayer Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000329","name":"Novo Nordisk Haemophilia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtha.2024.04.020","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T01:51:05Z","timestamp":1715046665000},"page":"2171-2183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["DNA base editing corrects common hemophilia A mutations and restores factor VIII expression in in\u00a0vitro and ex\u00a0vivo models"],"prefix":"10.1016","volume":"22","author":[{"given":"Elena","family":"Tonetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Follenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-9429","authenticated-orcid":false,"given":"Dario","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.04.020_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.020_bib2","doi-asserted-by":"crossref","first-page":"19587","DOI":"10.1074\/jbc.274.28.19587","article-title":"Expression of factor VIII by murine liver sinusoidal endothelial cells","volume":"274","author":"Do","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.04.020_bib3","first-page":"935","article-title":"Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice","volume":"118","author":"Follenzi","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.04.020_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2014.123117","article-title":"Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A","volume":"100","author":"Zanolini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.04.020_bib5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2017-08-800763","article-title":"Impacting inhibitor development in hemophilia A","volume":"130","author":"Konkle","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.04.020_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia A","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ymthe.2019.11.006","article-title":"A\u00a0molecular revolution in the treatment of hemophilia","volume":"28","author":"Butterfield","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2024.04.020_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMoa2113708","article-title":"Valoctocogene roxaparvovec gene therapy for hemophilia A","volume":"386","author":"Ozelo","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2016-01-687434","article-title":"Efficacy and safety of rVIII-SingleChain: results of a phase 1\/3 multicenter clinical trial in severe hemophilia A","volume":"128","author":"Mahlangu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear factor VIII expression after AAV gene transfer for hemophilia A","volume":"385","author":"George","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood-2020-137648","article-title":"Updated follow-up of the Alta Study, a phase 1\/2 study of giroctocogene fitelparvovec (SB-525) gene therapy in adults with severe hemophilia A","volume":"136","author":"Leavitt","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in\u00a0vivo gene therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtha.2024.04.020_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in\u00a0vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2024.04.020_bib16","article-title":"In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.04.020_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41467-022-28080-7","article-title":"Correction of a factor VIII genomic inversion with designer-recombinases","volume":"13","author":"Lansing","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.04.020_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0243-1","article-title":"Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs","volume":"51","author":"Sung","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","article-title":"In\u00a0vivo genome editing of the albumin locus as a platform for protein replacement therapy","volume":"126","author":"Sharma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1115831","article-title":"Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR\/Cas9 mediated gene editing","volume":"14","author":"Hu","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jtha.2024.04.020_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.aax7063","article-title":"A\u00a0cytosine deaminase for programmable single-base RNA editing","volume":"365","author":"Abudayyeh","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jtha.2024.04.020_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jtha.2024.04.020_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41467-018-08034-8","article-title":"Engineering of high-precision base editors for site-specific single nucleotide replacement","volume":"10","author":"Tan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.04.020_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jtha.2024.04.020_bib27","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.stem.2021.04.010","article-title":"Adenine base editing and prime editing of chemically derived hepatic progenitors rescue genetic liver disease","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtha.2024.04.020_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","article-title":"Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing","volume":"5","author":"Suh","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jtha.2024.04.020_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2661","article-title":"High-purity production and precise editing of DNA base editing ribonucleoproteins","volume":"7","author":"Jang","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2024.04.020_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In\u00a0vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in\u00a0vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.04.020_bib34","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2024.04.020_bib35","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2024.04.020_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/nar\/gkab1295","article-title":"Comprehensive analysis of prime editing outcomes in human embryonic stem cells","volume":"50","author":"Habib","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.04.020_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.13947","article-title":"The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: important resources for haemostasis clinicians and researchers","volume":"26","author":"McVey","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.04.020_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2024.04.020_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.V99.1.168","article-title":"Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A","volume":"99","author":"Bagnall","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib40","doi-asserted-by":"crossref","first-page":"W499","DOI":"10.1093\/nar\/gkab319","article-title":"PE-designer and PE-analyzer: web-based design and analysis tools for CRISPR prime editing","volume":"49","author":"Hwang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.04.020_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-0716-2879-9_2","article-title":"Web-based computational tools for base editors","volume":"2606","author":"Hwang","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtha.2024.04.020_bib42","doi-asserted-by":"crossref","first-page":"W505","DOI":"10.1093\/nar\/gkab427","article-title":"pegIT - a web-based design tool for prime editing","volume":"49","author":"Anderson","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.04.020_bib43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41551-020-00622-8","article-title":"A\u00a0web tool for the design of prime-editing guide RNAs","volume":"5","author":"Chow","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jtha.2024.04.020_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12859-018-2585-4","article-title":"Web-based design and analysis tools for CRISPR base editing","volume":"19","author":"Hwang","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jtha.2024.04.020_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2020.05.037","article-title":"Determinants of base editing outcomes from target library analysis and machine learning","volume":"182","author":"Arbab","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2024.04.020_bib46","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.04.020_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: a method to quantify base editing from Sanger sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J"},{"key":"10.1016\/j.jtha.2024.04.020_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.omtm.2021.10.015","article-title":"Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device","volume":"23","author":"Olgasi","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtha.2024.04.020_bib49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood.2019002867","article-title":"Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum","volume":"135","author":"Poothong","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V99.2.457","article-title":"Use of blood outgrowth endothelial cells for gene therapy for hemophilia A","volume":"99","author":"Lin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib51","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2013-12-545780","article-title":"Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response","volume":"123","author":"Ozelo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.020_bib52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/cells9071731","article-title":"The functionality of endothelial-colony-forming cells from patients with diabetes mellitus","volume":"9","author":"Lyons","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2024.04.020_bib53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa2211075","article-title":"Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A","volume":"388","author":"Mahlangu","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.04.020_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2024.04.020_bib55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtha.2024.04.020_bib57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In\u00a0vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.04.020_bib58","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2022.08.076","article-title":"Delivery of Cas9-guided ABE8e into stem cells using poly(l-lysine) polypeptides for correction of the hemophilia-associated FIX missense mutation","volume":"628","author":"Rong","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtha.2024.04.020_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-023-00286-w","article-title":"PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells","volume":"3","author":"Hiramoto","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.jtha.2024.04.020_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3324\/haematol.2017.178327","article-title":"Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity","volume":"103","author":"Donadon","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.04.020_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","article-title":"Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity","volume":"41","author":"Neugebauer","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib63","article-title":"Genotoxic effects of base and prime editing in human hematopoietic stem cells","author":"Fiumara","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41434-021-00282-6","article-title":"Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system","volume":"29","author":"O\u2019Keeffe Ahern","year":"2022","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtha.2024.04.020_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in\u00a0vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2024.04.020_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102116","article-title":"Immune tolerance promotion by LSEC-specific lentiviral vector-mediated expression of the transgene regulated by the stabilin-2 promoter","volume":"35","author":"Borroni","year":"2024","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T02:06:01Z","timestamp":1721700361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624002460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1538783624002460"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA base editing corrects common hemophilia A mutations and restores factor VIII expression in in\u00a0vitro and ex\u00a0vivo models","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}